Free Stock Screener
Load Save Create a watchlist Help
NBS.P
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions CAD) | 30 Dec 2020 | 29 Sep 2020 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | CAD$0.06501 | CAD$0.012334 | |||
Short term investments | CAD$0.203952 | CAD$0.254064 | |||
Net receivables | |||||
Inventory | |||||
Other current assets | |||||
Total current assets | CAD$0.268962 | CAD$0.266398 | |||
Long term investments | |||||
Property, plant & equipment | |||||
Goodwill | |||||
Intangible assets | |||||
Other assets | CAD$0.000001 | ||||
Deferred long term asset charges | |||||
Total assets | CAD$0.268963 | CAD$0.266398 | |||
Current liabilities | |||||
Accounts payable | -CAD$0.002251 | CAD$0.012071 | |||
Short long term debt | |||||
Other current liabilities | |||||
Total current liabilities | -CAD$0.002251 | CAD$0.012071 | |||
Long term debt | |||||
Other liabilities | |||||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | -CAD$0.002251 | CAD$0.012071 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | CAD$0.513959 | CAD$0.453906 | |||
Retained earnings | -CAD$0.30319 | -CAD$0.280827 | |||
Treasury stock | CAD$0.026501 | ||||
Capital surplus | CAD$0.060445 | CAD$0.054747 | |||
Other stockholder equity | CAD$0.026501 | ||||
Total stockholder equity | CAD$0.271214 | CAD$0.254327 | |||
Net tangible assets | CAD$0.271214 | CAD$0.254327 |
(in millions CAD) | 2020 | 2019 | ||
---|---|---|---|---|
Current assets | ||||
Cash | CAD$0.065763 | CAD$0.023796 | ||
Short term investments | CAD$0.253813 | CAD$0.40163 | ||
Net receivables | ||||
Inventory | ||||
Other current assets | ||||
Total current assets | CAD$0.3248 | CAD$0.428243 | ||
Long term investments | ||||
Property, plant & equipment | ||||
Goodwill | ||||
Intangible assets | ||||
Other assets | ||||
Deferred long term asset charges | ||||
Total assets | CAD$0.3248 | CAD$0.428243 | ||
Current liabilities | ||||
Accounts payable | CAD$0.031437 | |||
Short long term debt | ||||
Other current liabilities | ||||
Total current liabilities | CAD$0.031437 | |||
Long term debt | ||||
Other liabilities | ||||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | CAD$0.031437 | |||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | CAD$0.453906 | CAD$0.453906 | ||
Retained earnings | -CAD$0.241791 | -CAD$0.106911 | ||
Treasury stock | CAD$0.026501 | CAD$0.026501 | ||
Capital surplus | CAD$0.054747 | CAD$0.054747 | ||
Other stockholder equity | CAD$0.026501 | CAD$0.026501 | ||
Total stockholder equity | CAD$0.293363 | CAD$0.428243 | ||
Net tangible assets | CAD$0.293363 | CAD$0.428243 |
Income statement
(in millions CAD) | 30 Dec 2020 | 29 Sep 2020 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | |||||
Cost of revenue | |||||
Gross profit | |||||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | CAD$0.009988 | CAD$0.035188 | |||
Non-recurring | |||||
Other operating expenses | |||||
Total operating expenses | CAD$0.009988 | CAD$0.035188 | |||
Operating income | -CAD$0.009988 | -CAD$0.035188 | |||
Income from continuing operations | |||||
Net other income | -CAD$0.012375 | -CAD$0.003848 | |||
EBIT | -CAD$0.009988 | -CAD$0.035188 | |||
Interest expense | |||||
Income before tax | -CAD$0.022363 | -CAD$0.039036 | |||
Income tax expense | |||||
Minority interest | |||||
Net income from continuing ops | -CAD$0.022363 | -CAD$0.039036 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | -CAD$0.022363 | -CAD$0.039036 | |||
Income (for common shares) | -CAD$0.022363 | -CAD$0.039036 |
(in millions CAD) | 2020 | 2019 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | CAD$0.001795 | |||
Cost of revenue | ||||
Gross profit | CAD$0.001795 | |||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | CAD$0.119093 | CAD$0.039726 | ||
Non-recurring | ||||
Other operating expenses | ||||
Total operating expenses | CAD$0.119093 | CAD$0.094473 | ||
Operating income | -CAD$0.119093 | -CAD$0.094473 | ||
Income from continuing operations | ||||
Net other income | -CAD$0.015787 | -CAD$0.009661 | ||
EBIT | -CAD$0.119093 | -CAD$0.094473 | ||
Interest expense | ||||
Income before tax | -CAD$0.13488 | -CAD$0.104134 | ||
Income tax expense | ||||
Minority interest | ||||
Net income from continuing ops | -CAD$0.13488 | -CAD$0.104134 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | -CAD$0.13488 | -CAD$0.104134 | ||
Income (for common shares) | -CAD$0.13488 | -CAD$0.104134 |
Cash flows
(in millions CAD) | 30 Dec 2020 | 29 Sep 2020 | |||
---|---|---|---|---|---|
Net income | -CAD$0.022363 | -CAD$0.039036 | |||
Operating activities | |||||
Depreciation | |||||
Net income adjustments | |||||
Change in accounts receivable | |||||
Changes in liabilities | -CAD$0.014323 | -CAD$0.019366 | |||
Changes in inventory | |||||
Changes in other operating activities | CAD$0.005224 | ||||
Total cash flows from operations | -CAD$0.036686 | -CAD$0.053178 | |||
Investing activities | |||||
Capital expenditures | |||||
Investments | CAD$0.050111 | -CAD$0.000251 | |||
Other cash flows from investing | CAD$0.000001 | CAD$0.000001 | |||
Total cash flows from investing | CAD$0.050112 | -CAD$0.000251 | |||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | |||||
Other cash flows from financing | -CAD$0.026501 | -CAD$0.026501 | |||
Total cash flows from financing | CAD$0.03925 | CAD$0.03925 | |||
Effect of exchange rate | |||||
Change in cash and equivalents | CAD$0.052676 | -CAD$0.053429 |
(in millions CAD) | 2020 | 2019 | ||
---|---|---|---|---|
Net income | -CAD$0.13488 | -CAD$0.104134 | ||
Operating activities | ||||
Depreciation | ||||
Net income adjustments | CAD$0.054747 | |||
Change in accounts receivable | ||||
Changes in liabilities | CAD$0.031437 | -CAD$0.000283 | ||
Changes in inventory | ||||
Changes in other operating activities | -CAD$0.002407 | CAD$0.021223 | ||
Total cash flows from operations | -CAD$0.10585 | -CAD$0.028447 | ||
Investing activities | ||||
Capital expenditures | ||||
Investments | CAD$0.147817 | -CAD$0.40163 | ||
Other cash flows from investing | ||||
Total cash flows from investing | CAD$0.147817 | -CAD$0.40163 | ||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Other cash flows from financing | -CAD$0.134593 | |||
Total cash flows from financing | CAD$0.365407 | |||
Effect of exchange rate | ||||
Change in cash and equivalents | CAD$0.041967 | -CAD$0.06467 |
Quarterly EPS estimates
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions EUR) | 29 Sep 2022 | 29 Jun 2022 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | €88.383 | €46.792 | |||
Short term investments | €650.404 | ||||
Net receivables | €2,359.528 | €3,076.748 | |||
Inventory | €155.774 | €151.298 | |||
Other current assets | €240.175 | €410.606 | |||
Total current assets | €13,623.078 | €11,547.319 | |||
Long term investments | €23,603.183 | €25,638.323 | |||
Property, plant & equipment | €531.629 | €531.726 | |||
Goodwill | |||||
Intangible assets | €119.801 | €118.928 | |||
Other assets | €28,264.656 | €29,944.772 | |||
Deferred long term asset charges | €1,106.862 | €1,012.906 | |||
Total assets | €66,142.347 | €67,781.068 | |||
Current liabilities | |||||
Accounts payable | €2,958.36 | ||||
Short long term debt | |||||
Other current liabilities | -€410.192 | €2,352.709 | |||
Total current liabilities | -€410.192 | €5,446.416 | |||
Long term debt | €5,232.554 | €5,146.57 | |||
Other liabilities | €57,671.083 | €53,200.912 | |||
Deferred long term liabilities | |||||
Minority interest | -€8.082 | -€1.556 | |||
Total liabilities | €62,549.863 | €63,853.6 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | €1,486.253 | €490.13 | |||
Retained earnings | €3,542.34 | €3,478.335 | |||
Treasury stock | -€1,428.027 | -€1,035.563 | |||
Capital surplus | €996.122 | ||||
Other stockholder equity | -€1,428.027 | -€1,035.563 | |||
Total stockholder equity | €3,600.566 | €3,929.024 | |||
Net tangible assets | €3,480.765 | €3,810.096 |
(in millions EUR) | 2021 | 2020 | ||
---|---|---|---|---|
Current assets | ||||
Cash | €72.136 | €75.12 | ||
Short term investments | ||||
Net receivables | €350.767 | €338.883 | ||
Inventory | €192.56 | €178.204 | ||
Other current assets | €795.343 | €839.192 | ||
Total current assets | €9,293.229 | €7,900.009 | ||
Long term investments | €34,806.358 | €39,152.12 | ||
Property, plant & equipment | €511.739 | €488.44 | ||
Goodwill | ||||
Intangible assets | €114.398 | €104.764 | ||
Other assets | €30,487.202 | €28,842.309 | ||
Deferred long term asset charges | €155.158 | €230.073 | ||
Total assets | €75,212.926 | €76,487.642 | ||
Current liabilities | ||||
Accounts payable | €3,097.076 | €2,816.163 | ||
Short long term debt | ||||
Other current liabilities | €923.705 | €1,175.563 | ||
Total current liabilities | €4,195.981 | €4,088.126 | ||
Long term debt | €4,653.076 | €3,965.665 | ||
Other liabilities | €61,423.63 | €63,265.485 | ||
Deferred long term liabilities | ||||
Minority interest | €28.727 | €42.494 | ||
Total liabilities | €70,339.352 | €71,402.491 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | €489.893 | €490.231 | ||
Retained earnings | €3,441.733 | €3,158.949 | ||
Treasury stock | -€82.474 | €397.245 | ||
Capital surplus | €995.695 | €996.232 | ||
Other stockholder equity | -€82.474 | €397.245 | ||
Total stockholder equity | €4,844.847 | €5,042.657 | ||
Net tangible assets | €4,730.449 | €4,937.893 |
Income statement
(in millions EUR) | 29 Sep 2022 | 29 Jun 2022 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | €1,520.691 | €885.584 | |||
Cost of revenue | €1,053.967 | €596.088 | |||
Gross profit | €466.724 | €289.496 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | €229.314 | €223.552 | |||
Non-recurring | |||||
Other operating expenses | -€48.716 | -€6.886 | |||
Total operating expenses | €1,253.089 | €829.181 | |||
Operating income | €267.602 | €56.403 | |||
Income from continuing operations | |||||
Net other income | -€184.811 | -€3.974999 | |||
EBIT | €267.602 | €56.403 | |||
Interest expense | -€103.346 | -€85.44 | |||
Income before tax | €82.791 | €52.428 | |||
Income tax expense | €18.613 | €13.065 | |||
Minority interest | -€8.082 | -€1.556 | |||
Net income from continuing ops | €64.178 | €39.363 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | €63.982 | €40.46 | |||
Income (for common shares) | €63.982 | €40.46 |
(in millions EUR) | 2021 | 2020 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | €7,866.025 | €7,064.676 | ||
Cost of revenue | €5,967.772 | €5,265.015 | ||
Gross profit | €1,898.253 | €1,799.661 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | €961.177 | €936.578 | ||
Non-recurring | ||||
Other operating expenses | -€60.069 | -€41.413 | ||
Total operating expenses | €6,942.184 | €6,237.599 | ||
Operating income | €923.841 | €827.077 | ||
Income from continuing operations | ||||
Net other income | -€443.182 | -€520.204 | ||
EBIT | €923.841 | €827.077 | ||
Interest expense | -€430.557 | -€472 | ||
Income before tax | €480.659 | €306.873 | ||
Income tax expense | €128.506 | €96.122 | ||
Minority interest | €28.727 | €42.494 | ||
Net income from continuing ops | €352.153 | €210.751 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | €350.525 | €209.907 | ||
Income (for common shares) | €350.525 | €209.907 |
Cash flows
(in millions EUR) | 29 Sep 2022 | 29 Jun 2022 | |||
---|---|---|---|---|---|
Net income | €63.982 | €40.46 | |||
Operating activities | |||||
Depreciation | |||||
Net income adjustments | |||||
Change in accounts receivable | |||||
Changes in liabilities | |||||
Changes in inventory | |||||
Changes in other operating activities | |||||
Total cash flows from operations | |||||
Investing activities | |||||
Capital expenditures | |||||
Investments | |||||
Other cash flows from investing | |||||
Total cash flows from investing | |||||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | |||||
Other cash flows from financing | |||||
Total cash flows from financing | |||||
Effect of exchange rate | |||||
Change in cash and equivalents |
(in millions EUR) | 2021 | 2020 | ||
---|---|---|---|---|
Net income | €350.525 | €209.907 | ||
Operating activities | ||||
Depreciation | €116.662 | €114.049 | ||
Net income adjustments | €127.019 | €44.828 | ||
Change in accounts receivable | ||||
Changes in liabilities | ||||
Changes in inventory | ||||
Changes in other operating activities | -€1,420.401 | -€450.415 | ||
Total cash flows from operations | -€795.988 | €434.954 | ||
Investing activities | ||||
Capital expenditures | -€116.955 | -€159.823 | ||
Investments | €464.372 | -€491.189 | ||
Other cash flows from investing | ||||
Total cash flows from investing | €350.93 | -€266.632 | ||
Financing activities | ||||
Dividends paid | -€60.885 | -€60.927 | ||
Sale and purchase of stock | ||||
Net borrowings | €276.978 | €58.768 | ||
Other cash flows from financing | -€18.72 | -€18.797 | ||
Total cash flows from financing | €197.373 | -€20.956 | ||
Effect of exchange rate | €26.489 | €0.95 | ||
Change in cash and equivalents | -€221.196 | €148.316 |
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 29 Nov 2021 | 30 Aug 2021 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | |||||
Short term investments | |||||
Net receivables | $2.763437 | $2.763437 | |||
Inventory | |||||
Total current assets | $2.769976 | $2.769976 | |||
Long term investments | $22.947838 | $22.947838 | |||
Property, plant & equipment | |||||
Goodwill & intangible assets | |||||
Total noncurrent assets | |||||
Total investments | |||||
Total assets | $98.685663 | $98.685663 | |||
Current liabilities | |||||
Accounts payable | |||||
Deferred revenue | |||||
Short long term debt | |||||
Total current liabilities | $10.30335 | $10.30335 | |||
Long term debt | $5.192 | $5.192 | |||
Total noncurrent liabilities | |||||
Total debt | |||||
Total liabilities | $15.49535 | $15.49535 | |||
Stockholders' equity | |||||
Retained earnings | -$4.306687 | -$4.306687 | |||
Other stockholder equity | |||||
Total stockholder equity | $83.190313 | $83.190313 |
(in millions USD) | 2021 | 2020 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $3.410447 | |||
Short term investments | ||||
Net receivables | $2.763437 | $0.117366 | ||
Inventory | ||||
Total current assets | $2.769976 | $3.533381 | ||
Long term investments | $22.947838 | $11.789166 | ||
Property, plant & equipment | ||||
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $98.685663 | $81.947431 | ||
Current liabilities | ||||
Accounts payable | $3.410447 | |||
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $10.30335 | $20.101534 | ||
Long term debt | $5.192 | $5.192 | ||
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $15.49535 | $26.929688 | ||
Stockholders' equity | ||||
Retained earnings | -$4.306687 | -$38.648444 | ||
Other stockholder equity | ||||
Total stockholder equity | $83.190313 | $55.017743 |
Income statement
(in millions USD) | 29 Nov 2021 | 30 Aug 2021 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | $0.077565 | $0.077565 | |||
Cost of revenue | |||||
Gross profit | $0.077565 | $0.077565 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $0.402832 | $0.402832 | |||
Total operating expenses | $0.402832 | $0.402832 | |||
Operating income | -$0.325268 | -$0.325268 | |||
Income from continuing operations | |||||
EBIT | -$0.325268 | -$0.325268 | |||
Income tax expense | -$1.36963 | -$1.36963 | |||
Interest expense | -$0.045275 | -$0.045275 | |||
Net income | |||||
Net income | -$0.780367 | -$0.780367 | |||
Income (for common shares) | -$0.780367 | -$0.780367 |
(in millions USD) | 2021 | 2020 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | $0.268617 | $1.553474 | ||
Cost of revenue | ||||
Gross profit | $0.268617 | $1.553474 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $1.497582 | $2.676854 | ||
Total operating expenses | $1.497582 | $2.676854 | ||
Operating income | -$1.228965 | -$1.12338 | ||
Income from continuing operations | ||||
EBIT | -$1.228965 | -$1.12338 | ||
Income tax expense | -$6.518929 | -$1.698271 | ||
Interest expense | -$0.183771 | -$1.474379 | ||
Net income | ||||
Net income | $34.341757 | -$203.677203 | ||
Income (for common shares) | $34.341757 | -$203.677203 |
Cash flows
(in millions USD) | 29 Nov 2021 | 30 Aug 2021 | |||
---|---|---|---|---|---|
Net income | -$0.780367 | -$0.780367 | |||
Operating activities | |||||
Depreciation | |||||
Business acquisitions & disposals | |||||
Stock-based compensation | |||||
Total cash flows from operations | $1.731905 | $1.731905 | |||
Investing activities | |||||
Capital expenditures | |||||
Investments | |||||
Total cash flows from investing | |||||
Financing activities | |||||
Dividends paid | -$1.736598 | -$1.736598 | |||
Sale and purchase of stock | |||||
Net borrowings | $0.004693 | $0.004693 | |||
Total cash flows from financing | -$1.731905 | -$1.731905 | |||
Effect of exchange rate | |||||
Change in cash and equivalents |
(in millions USD) | 2021 | 2020 | ||
---|---|---|---|---|
Net income | $34.341757 | -$203.677203 | ||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $2.801976 | $182.658497 | ||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | ||||
Financing activities | ||||
Dividends paid | -$6.946391 | -$16.075933 | ||
Sale and purchase of stock | ||||
Net borrowings | $0.010096 | -$163.168117 | ||
Total cash flows from financing | -$6.212423 | -$179.24805 | ||
Effect of exchange rate | ||||
Change in cash and equivalents | -$3.410447 | $3.410447 |
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 31 Mar 2015 | 31 Dec 2014 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $0.02 | ||||
Short term investments | |||||
Net receivables | $0.05 | ||||
Inventory | |||||
Other current assets | |||||
Total current assets | $0.27 | ||||
Long term investments | |||||
Property, plant & equipment | $14.74 | ||||
Goodwill | |||||
Intangible assets | |||||
Other assets | $14.88 | ||||
Deferred long term asset charges | |||||
Total assets | $14.88 | $15.04 | |||
Current liabilities | |||||
Accounts payable | |||||
Short long term debt | $10.03 | ||||
Other current liabilities | $13.37 | ||||
Total current liabilities | $14.46 | $11.63 | |||
Long term debt | |||||
Other liabilities | |||||
Deferred long term liabilities | |||||
Minority interest | -$0.35 | -$0.35 | |||
Total liabilities | $14.11 | $11.28 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | |||||
Retained earnings | -$16.15 | -$14.38 | |||
Treasury stock | |||||
Capital surplus | |||||
Other stockholder equity | -$0.79 | $0.95 | |||
Total stockholder equity | $0.77 | $3.76 | |||
Net tangible assets |
(in millions USD) | 2014 | 2013 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $0.02 | |||
Short term investments | ||||
Net receivables | $0.05 | |||
Inventory | ||||
Other current assets | ||||
Total current assets | $0.27 | |||
Long term investments | ||||
Property, plant & equipment | $14.74 | |||
Goodwill | ||||
Intangible assets | ||||
Other assets | ||||
Deferred long term asset charges | ||||
Total assets | $15.04 | |||
Current liabilities | ||||
Accounts payable | ||||
Short long term debt | $10.03 | $0.01 | ||
Other current liabilities | ||||
Total current liabilities | $11.63 | $0.01 | ||
Long term debt | ||||
Other liabilities | ||||
Deferred long term liabilities | ||||
Minority interest | -$0.35 | |||
Total liabilities | $11.28 | $0.01 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | ||||
Retained earnings | -$14.38 | -$0.07 | ||
Treasury stock | ||||
Capital surplus | ||||
Other stockholder equity | $0.95 | |||
Total stockholder equity | $3.76 | |||
Net tangible assets |
Income statement
(in millions USD) | 31 Mar 2015 | 31 Dec 2014 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | $0.25 | ||||
Cost of revenue | |||||
Gross profit | |||||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $0.45 | $5.38 | |||
Non-recurring | |||||
Other operating expenses | |||||
Total operating expenses | $0.45 | $8.96 | |||
Operating income | -$0.45 | -$8.72 | |||
Income from continuing operations | |||||
Net other income | |||||
EBIT | |||||
Interest expense | |||||
Income before tax | -$0.45 | -$9.12 | |||
Income tax expense | |||||
Minority interest | $0.35 | ||||
Net income from continuing ops | |||||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | -$1.32 | ||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | -$1.77 | -$8.77 | |||
Income (for common shares) | -$1.77 | -$8.77 |
(in millions USD) | 2013 | 2012 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | $0.01 | |||
Cost of revenue | $0.01 | |||
Gross profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $0.04 | $0.03 | ||
Non-recurring | ||||
Other operating expenses | ||||
Total operating expenses | $0.06 | $0.03 | ||
Operating income | -$0.04 | -$0.03 | ||
Income from continuing operations | ||||
Net other income | ||||
EBIT | ||||
Interest expense | ||||
Income before tax | -$0.04 | -$0.03 | ||
Income tax expense | ||||
Minority interest | ||||
Net income from continuing ops | ||||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | -$0.04 | -$0.03 | ||
Income (for common shares) | -$0.04 | -$0.03 |
Cash flows
(in millions USD) | 31 Mar 2015 | 31 Dec 2014 | |||
---|---|---|---|---|---|
Net income | -$1.77 | -$9.12 | |||
Operating activities | |||||
Depreciation | $0.02 | ||||
Net income adjustments | |||||
Change in accounts receivable | |||||
Changes in liabilities | |||||
Changes in inventory | |||||
Changes in other operating activities | |||||
Total cash flows from operations | -$1.81 | -$0.52 | |||
Investing activities | |||||
Capital expenditures | -$0.2 | ||||
Investments | |||||
Other cash flows from investing | $0.19 | ||||
Total cash flows from investing | -$0.02 | ||||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | $1.1 | ||||
Net borrowings | -$0.45 | ||||
Other cash flows from financing | $3.53 | ||||
Total cash flows from financing | $3.53 | $0.66 | |||
Effect of exchange rate | -$1.74 | -$0.13 | |||
Change in cash and equivalents | -$0.01 | -$0.01 |
(in millions USD) | 2014 | 2013 | ||
---|---|---|---|---|
Net income | -$14.73 | -$0.04 | ||
Operating activities | ||||
Depreciation | $0.02 | |||
Net income adjustments | ||||
Change in accounts receivable | ||||
Changes in liabilities | ||||
Changes in inventory | ||||
Changes in other operating activities | ||||
Total cash flows from operations | -$3.07 | -$0.05 | ||
Investing activities | ||||
Capital expenditures | -$4.37 | |||
Investments | ||||
Other cash flows from investing | -$3.47 | |||
Total cash flows from investing | -$7.85 | |||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | $9.11 | $0.04 | ||
Net borrowings | $1.95 | |||
Other cash flows from financing | $0.01 | |||
Total cash flows from financing | $11.07 | $0.05 | ||
Effect of exchange rate | -$0.13 | |||
Change in cash and equivalents | $0.02 |
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 30 Nov 2013 | 31 Aug 2013 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | |||||
Short term investments | |||||
Net receivables | |||||
Inventory | |||||
Other current assets | |||||
Total current assets | |||||
Long term investments | |||||
Property, plant & equipment | |||||
Goodwill | |||||
Intangible assets | |||||
Other assets | |||||
Deferred long term asset charges | |||||
Total assets | |||||
Current liabilities | |||||
Accounts payable | $0.01 | $0.01 | |||
Short long term debt | $0.18 | $0.18 | |||
Other current liabilities | $1.57 | $1.24 | |||
Total current liabilities | $1.78 | $1.45 | |||
Long term debt | |||||
Other liabilities | |||||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | $1.78 | $1.45 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | $0.17 | $0.14 | |||
Retained earnings | -$16.34 | -$15.85 | |||
Treasury stock | |||||
Capital surplus | |||||
Other stockholder equity | |||||
Total stockholder equity | -$1.78 | -$1.45 | |||
Net tangible assets |
(in millions USD) | 2013 | 2012 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $0.01 | |||
Short term investments | ||||
Net receivables | ||||
Inventory | ||||
Other current assets | ||||
Total current assets | $0.01 | |||
Long term investments | ||||
Property, plant & equipment | ||||
Goodwill | ||||
Intangible assets | ||||
Other assets | ||||
Deferred long term asset charges | ||||
Total assets | $0.01 | |||
Current liabilities | ||||
Accounts payable | $0.05 | $0.04 | ||
Short long term debt | $0.04 | $0.04 | ||
Other current liabilities | $0.1 | $0.24 | ||
Total current liabilities | $0.19 | $0.32 | ||
Long term debt | ||||
Other liabilities | ||||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | $0.19 | $0.32 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | $0.12 | $0.1 | ||
Retained earnings | -$14.44 | -$14.47 | ||
Treasury stock | ||||
Capital surplus | ||||
Other stockholder equity | ||||
Total stockholder equity | -$0.19 | -$0.31 | ||
Net tangible assets |
Income statement
(in millions USD) | 30 Nov 2013 | 31 Aug 2013 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | |||||
Cost of revenue | |||||
Gross profit | |||||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $0.12 | $0.08 | |||
Non-recurring | |||||
Other operating expenses | |||||
Total operating expenses | $0.16 | $0.17 | |||
Operating income | -$0.16 | -$0.17 | |||
Income from continuing operations | |||||
Net other income | |||||
EBIT | |||||
Interest expense | |||||
Income before tax | -$0.49 | $0.44 | |||
Income tax expense | |||||
Minority interest | |||||
Net income from continuing ops | |||||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | -$0.49 | $0.44 | |||
Income (for common shares) | -$0.49 | $0.44 |
(in millions USD) | 2013 | 2012 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | ||||
Cost of revenue | ||||
Gross profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $0.11 | $1.97 | ||
Non-recurring | ||||
Other operating expenses | ||||
Total operating expenses | $0.11 | $1.97 | ||
Operating income | -$0.11 | -$1.97 | ||
Income from continuing operations | ||||
Net other income | ||||
EBIT | ||||
Interest expense | ||||
Income before tax | $0.03 | -$2.2 | ||
Income tax expense | ||||
Minority interest | ||||
Net income from continuing ops | ||||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | $0.03 | -$2.2 | ||
Income (for common shares) | $0.03 | -$2.2 |
Cash flows
(in millions USD) | 30 Nov 2013 | 31 Aug 2013 | ||
---|---|---|---|---|
Net income | -$0.48 | $0.44 | ||
Operating activities | ||||
Depreciation | ||||
Net income adjustments | ||||
Change in accounts receivable | ||||
Changes in liabilities | ||||
Changes in inventory | ||||
Changes in other operating activities | ||||
Total cash flows from operations | -$0.01 | |||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Other cash flows from investing | ||||
Total cash flows from investing | ||||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | $0.01 | |||
Other cash flows from financing | ||||
Total cash flows from financing | $0.01 | |||
Effect of exchange rate | ||||
Change in cash and equivalents |
(in millions USD) | 2013 | 2012 | ||
---|---|---|---|---|
Net income | $0.03 | -$2.2 | ||
Operating activities | ||||
Depreciation | ||||
Net income adjustments | ||||
Change in accounts receivable | ||||
Changes in liabilities | ||||
Changes in inventory | ||||
Changes in other operating activities | ||||
Total cash flows from operations | -$0.03 | -$0.35 | ||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Other cash flows from investing | ||||
Total cash flows from investing | ||||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | $0.35 | |||
Net borrowings | $0.02 | $0.01 | ||
Other cash flows from financing | ||||
Total cash flows from financing | $0.02 | $0.36 | ||
Effect of exchange rate | ||||
Change in cash and equivalents | -$0.01 | $0.01 |